Oncology

Companies Oncology

Alpine Institute for Drug Discovery SA, Switzerland

The Alpine Institute for Drug Discovery is a Switzerland-based company aiming at creating shared value for the community by maintaining industrial know-how in today’s changing pharmaceutical landscape. AiDD’s mission is to maximise the socio-economical impact of academic discoveries by performing tr more

Amal Therapeutics SA, Switzerland

Amal Therapeutics SA is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Amal was incorporated on September 3rd 2012 and secured seed funding in February 2014 to establish and validate its technology platform. Boehringer Ingelheim Venture Fund led this in more

News Oncology

• Removal Of Tumor Cells From Surgical Blood
  

  As is standard during tumor surgeries, when large volumes of blood are lost, donor blood is given to the patient. Worldwide, this is the case for more than half a million tumor surgeries annually. This procedure can result in many serious side effects and increased tumor recurrence rates. However, s more

• Evotec and Takeda enter collaboration agreement to discover clinical candidates across multiple therapeutic areas

  Evotec SE announced a strategic, multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Under the collaboration, the parties aim to establish at least five drug discovery programmes with the goal of Evotec delivering clinical candidates for Takeda to pursue into clinical more

• A clearer cancer test by measuring immune response
  

  The European Patent Office (EPO) today announced that French immunologist Jérôme Galon has been nominated for the European Inventor Award 2019 for his diagnostic cancer test based on a patient's immune response. His invention, which has improved the accuracy of cancer prognosis, uses clues found in more

Publications Oncology

• Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan

  by Lisa Jane Mackenzie, Mariko Leanne Carey, Eiji Suzuki, Robert William Sanson-Fisher, Hiromi Asada, Masakazu Ogura, Catherine D’Este, Michio Yoshimura, Masakazu Toi This study assessed agreement between radiation oncologist- and cancer patient-reported perceptions about cancer diagnosis, time s more

• Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials

  We examined the impact of race on the maximum tolerated doses (MTD) and final approved doses (FAD) of single-agent molecular-targeted agents (MTA) in North America/Europe (NA/EU) and Asia. We searched PubMed and regulatory databases to identify targeted drugs approved globally and compared their FAD more

• Artificial intelligence in radiology

  Artificial intelligence (AI) algorithms, particularly deep learning, have demonstrated remarkable progress in image-recognition tasks. Methods ranging from convolutional neural networks to variational autoencoders have found myriad applications in the medical image analysis field, propelling it forw more